Quick Summary:
In the rapidly expanding Genomics and Proteomics Reagents, Research Kits and Analytical Instruments industry, the importance of reliable market insights and forward-looking data cannot be overstated. Undoubtedly, strategic planning and informed decision-making are the cornerstones of success in this dynamic landscape, and our market research report provides just that. Armed with up-to-date market trends, comprehensive data, and in-depth analysis, this report helps unleash new opportunities in the industry and assists your business in staying ahead of the competition.
The report not only provides numerical data but also interprets, makes sense of, and brings to light the crucial market trends and industry developments. In essence, this is a valuable tool in planning your company’s future strategies in the ever-evolving genomics and proteomics landscape. Acquiring this report is the first step you take in attaining a clear, concise, and data-driven insight into your industry's growth prospects and market dynamics. It’s high time you empower your business with the knowledge necessary to make critical decisions with confidence and precision.
Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market to Reach $156.5 Billion by 2030
The global market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments estimated at US$71.2 Billion in the year 2022, is projected to reach a revised size of US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2022-2030. Biochips & Microarrays, one of the segments analyzed in the report, is projected to record 9.1% CAGR and reach US$43.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sample Preparation Kits segment is readjusted to a revised 11.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $19.2 Billion, While China is Forecast to Grow at 13.8% CAGR
The Genomics and Proteomics Reagents, Research Kits and Analytical Instruments market in the U.S. is estimated at US$19.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$34.6 Billion by the year 2030 trailing a CAGR of 13.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 8.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.Select Competitors (Total 11 Featured) -
- Agilent Technologies, Inc.
- Illumina, Inc.
- Life Technologies Corporation
- Qiagen NV
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments?
What is the growth rate of the Global Market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments?
What is the forecasted size of the Global Market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments?
Who are the key companies in the Global Market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments?
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 71.2 Billion |
| Forecasted Market Value ( USD | $ 156.5 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Agilent Technologies, Inc.
- Illumina, Inc.
- Life Technologies Corporation
- Qiagen NV
- Thermo Fisher Scientific, Inc.
